Low fecal calprotectin predicts sustained clinical remission in inflammatory bowel disease patients: a plea for deep remission.
about
Optimizing biologic treatment in IBD: objective measures, but when, how and how often?Histologic scoring indices for evaluation of disease activity in ulcerative colitis.Diet, gut microbes, and the pathogenesis of inflammatory bowel diseases.Development and validation of a biomarker for diarrhea-predominant irritable bowel syndrome in human subjects.Elevated fecal peptidase D at onset of colitis in Galphai2-/- mice, a mouse model of IBDRelationship of clinical symptoms with biomarkers of inflammation in pediatric inflammatory bowel disease.Inter- and intraobserver agreement in computed tomography enterography in inflammatory bowel disease.Clinical Utility of Biomarkers in IBD.Fecal calprotectin: its scope and utility in the management of inflammatory bowel disease.Beyond Histological Remission: Intramucosal Calprotectin as a Potential Predictor of Outcomes in Ulcerative Colitis.The prevalence of irritable bowel syndrome-type symptoms in paediatric inflammatory bowel disease, and the relationship with biochemical markers of disease activity.Low Fecal Calprotectin Correlates with Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohn's Disease.Fecal calprotectin and its correlation with inflammatory markers and endoscopy in patients from India with inflammatory bowel disease.Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up.Short-term treatment with eicosapentaenoic acid improves inflammation and affects colonic differentiation markers and microbiota in patients with ulcerative colitis.Standardizing Fecal Calprotectin Monitoring in Asymptomatic Patients with Inflammatory Bowel Disease.Letter: how to define remission in ulcerative colitis - histological remission should be considered. Authors' reply.Fecal Calprotectin: A Reliable Predictor of Mucosal Healing after Treatment for Active Ulcerative Colitis.How will new and future therapies change our treatment of IBD?Fecal Calprotectin in Monitoring the Disease Activity in Colonic Inflammatory Bowel Disease.Can faecal calprotectin predict relapse in inflammatory bowel disease: a mini review.Fecal Immunochemical Test and Fecal Calprotectin Measurement Are Noninvasive Monitoring Tools for Predicting Endoscopic Activity in Patients with Ulcerative Colitis.The utility of fecal calprotectin in predicting the need for escalation of therapy in inflammatory bowel disease.Response to Levenstein and Prantera.An update on diagnostic and prognostic biomarkers in inflammatory bowel disease.Faecal chitinase 3-like 1 is a reliable marker as accurate as faecal calprotectin in detecting endoscopic activity in adult patients with inflammatory bowel diseases.Undetectable anti-TNF drug levels in patients with long-term remission predict successful drug withdrawal.Endoscopic Factors Influencing Fecal Calprotectin Value in Crohn's Disease.Endoscopic score vs. fecal biomarkers for predicting relapse in patients with ulcerative colitis after clinical remission and mucosal healing.Validation of a care pathway for the use of faecal calprotectin in monitoring patients with Crohn's disease.Expert opinion for use of faecal calprotectin in diagnosis and monitoring of inflammatory bowel disease in daily clinical practiceFrom bench to bedside: Fecal calprotectin in inflammatory bowel diseases clinical setting
P2860
Q26775064-F209B15F-6F15-48C7-9E3D-2D83634F5383Q30234366-E869E656-4E01-4997-BC1A-F27EEAEE2D73Q30249313-DC0A1A3B-CB7F-49A2-AB79-4CD636E9F152Q35603014-55841344-D3A6-4B7A-874D-DF296CCD922CQ36316461-42668149-D287-4A82-B0F2-886A13BD8B5CQ37273489-DA38F83F-A669-4C44-83B3-E0200D9BC47CQ37483425-4F243AE6-19DD-4D8C-B238-BFF7ECC52E32Q38539968-F34DB809-4305-4F61-BC8B-0C341FF0282FQ38742261-DF599D4E-6957-43C9-96B9-E3835940E703Q39179611-D5265318-38BD-479A-A959-621DAA8E84B1Q39825139-B71522CF-AA95-4BD3-8DBE-508DACA8C675Q40038096-D4F8D013-6D41-48FC-98E3-848AC947C4C1Q40295402-648ECA75-B55F-4792-AAC7-98551EBC1C1DQ40926333-C12D90A9-D718-42EE-8BE0-01622722ED9EQ41287600-7EA5182D-EACC-4C55-BD74-E292448B3189Q45209785-0CEED64D-3FEC-4EB8-9D1C-8FFE78EE76B8Q48095019-6C8DCA7D-C459-419A-9C2D-8AD1FB3A2B49Q48147122-CA2AA4AD-EF82-494D-80D0-ACFAF78D1D49Q48324608-38CB93D7-4FA7-4A28-8F9D-B11131087C15Q50086215-AA03A03B-BF60-4A49-BFC6-1879241EABACQ52372411-BE82CDA5-E493-4FD3-BE5C-8A00C5D562ECQ52372724-7D249676-7302-46DC-A183-6131F35C1099Q52676637-6C67DFAF-8005-4B76-BF94-B970BC8F0164Q52813914-530B13FF-4286-4DE2-BD2A-E31D96092435Q53128510-8C8690A0-3900-42CC-AC96-D5228F6E1BC8Q53208202-2536DB5F-8D00-4A0D-ADC7-3B2E326F84B8Q53482526-5324E362-27C4-41D0-B950-2AC6C40FAD8EQ53544370-9FC187DE-024B-4DD1-8B0D-31F3B12997D9Q55029613-91B39DBE-898D-47AB-9F27-7CC44ECF3DA7Q55652317-EDC7D10E-CBBD-489E-93A3-DBE50E920DECQ57063313-68F734CD-C6C1-4365-978F-FE694F7882BDQ58760402-26D9746B-0974-46A1-88C9-7B88D3AE0CC9
P2860
Low fecal calprotectin predicts sustained clinical remission in inflammatory bowel disease patients: a plea for deep remission.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Low fecal calprotectin predict ...... ts: a plea for deep remission.
@en
Low fecal calprotectin predict ...... ts: a plea for deep remission.
@nl
type
label
Low fecal calprotectin predict ...... ts: a plea for deep remission.
@en
Low fecal calprotectin predict ...... ts: a plea for deep remission.
@nl
prefLabel
Low fecal calprotectin predict ...... ts: a plea for deep remission.
@en
Low fecal calprotectin predict ...... ts: a plea for deep remission.
@nl
P2093
P2860
P356
P1476
Low fecal calprotectin predict ...... ts: a plea for deep remission.
@en
P2093
Bas Oldenburg
Erik Mooiweer
Herma H Fidder
Marguerite E I Schipper
Mirjam Severs
Peter D Siersema
Robert J F Laheij
P2860
P356
10.1093/ECCO-JCC/JJU003
P577
2014-11-26T00:00:00Z